Page last updated: 2024-08-17

uridine triphosphate and cystic fibrosis transmembrane conductance regulator (505-511)

uridine triphosphate has been researched along with cystic fibrosis transmembrane conductance regulator (505-511) in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
König, J; Kunzelmann, K; Mall, M; Schreiber, R	1

Other Studies

1 other study(ies) available for uridine triphosphate and cystic fibrosis transmembrane conductance regulator (505-511)

Article	Year
No evidence for inhibition of ENaC through CFTR-mediated release of ATP. Biochimica et biophysica acta, 2002, Sep-20, Volume: 1565, Issue:1 Topics: 1-Methyl-3-isobutylxanthine; Adenosine Triphosphate; Amiloride; Animals; Colon; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cystic Fibrosis Transmembrane Conductance Regulator; Electric Conductivity; Enzyme Inhibitors; Epithelial Sodium Channels; In Vitro Techniques; Mice; Nucleoside-Diphosphate Kinase; Oocytes; Peptide Fragments; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Sodium Channels; Uridine Triphosphate; Xenopus	2002

Article

Year

No evidence for inhibition of ENaC through CFTR-mediated release of ATP.

Biochimica et biophysica acta, 2002, Sep-20, Volume: 1565, Issue:1

Topics: 1-Methyl-3-isobutylxanthine; Adenosine Triphosphate; Amiloride; Animals; Colon; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Cystic Fibrosis Transmembrane Conductance Regulator; Electric Conductivity; Enzyme Inhibitors; Epithelial Sodium Channels; In Vitro Techniques; Mice; Nucleoside-Diphosphate Kinase; Oocytes; Peptide Fragments; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Sodium Channels; Uridine Triphosphate; Xenopus

2002